BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22496212)

  • 21. Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
    Peeters B; Reemers S; Dortmans J; de Vries E; de Jong M; van de Zande S; Rottier PJM; de Haan CAM
    Virology; 2017 Mar; 503():83-93. PubMed ID: 28135661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.
    Crevar CJ; Carter DM; Lee KY; Ross TM
    Hum Vaccin Immunother; 2015; 11(3):572-83. PubMed ID: 25671661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens.
    Jadhao SJ; Lee CW; Sylte M; Suarez DL
    Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Construction and immunogenicity of attenuated Salmonella typhimurium harbouring stable DNA vaccine against H5 subtype of avian influenza virus].
    Tang LH; Pan ZM; Cheng NN; Jiao XA; Zhang XM
    Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):662-6. PubMed ID: 17944368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
    Sun X; Belser JA; Pulit-Penaloza JA; Creager HM; Guo Z; Jefferson SN; Liu F; York IA; Stevens J; Maines TR; Jernigan DB; Katz JM; Levine MZ; Tumpey TM
    Virology; 2017 Aug; 508():164-169. PubMed ID: 28554058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and mice.
    Rao S; Kong WP; Wei CJ; Yang ZY; Nason M; Styles D; DeTolla LJ; Panda A; Sorrell EM; Song H; Wan H; Ramirez-Nieto GC; Perez D; Nabel GJ
    PLoS One; 2008; 3(6):e2432. PubMed ID: 19293944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses.
    Chen MW; Cheng TJ; Huang Y; Jan JT; Ma SH; Yu AL; Wong CH; Ho DD
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13538-43. PubMed ID: 18765801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix M Adjuvanted H5N1 Vaccine Elicits Broadly Neutralizing Antibodies and Neuraminidase Inhibiting Antibodies in Humans That Correlate With
    Zhou F; Hansen L; Pedersen G; Grødeland G; Cox R
    Front Immunol; 2021; 12():747774. PubMed ID: 34887855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses.
    Wang S; Hackett A; Jia N; Zhang C; Zhang L; Parker C; Zhou A; Li J; Cao WC; Huang Z; Li Y; Lu S
    PLoS One; 2011; 6(12):e28757. PubMed ID: 22205966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.
    He F; Prabakaran M; Rajesh Kumar S; Tan Y; Kwang J
    Antiviral Res; 2014 May; 105():143-51. PubMed ID: 24637255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination.
    Wei CJ; Boyington JC; McTamney PM; Kong WP; Pearce MB; Xu L; Andersen H; Rao S; Tumpey TM; Yang ZY; Nabel GJ
    Science; 2010 Aug; 329(5995):1060-4. PubMed ID: 20647428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens.
    Wang J; Ge A; Xu M; Wang Z; Qiao Y; Gu Y; Liu C; Liu Y; Hou J
    Virol J; 2015 Aug; 12():126. PubMed ID: 26263920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective efficacy of an inactivated chimeric H5 avian influenza vaccine against H5 highly pathogenic avian influenza virus clades 2.3.4.4 and 2.3.2.1.
    Li J; Hou G; Wang Y; Wang S; Cheng S; Peng C; Jiang W
    J Gen Virol; 2018 Dec; 99(12):1600-1607. PubMed ID: 30358528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus.
    Xu K; Ling ZY; Sun L; Xu Y; Bian C; He Y; Lu W; Chen Z; Sun B
    Viral Immunol; 2011 Feb; 24(1):45-56. PubMed ID: 21319978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
    Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved immune responses against avian influenza virus following oral vaccination of chickens with HA DNA vaccine using attenuated Salmonella typhimurium as carrier.
    Jazayeri SD; Ideris A; Zakaria Z; Yeap SK; Omar AR
    Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):417-27. PubMed ID: 22512819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza.
    Steel J; Lowen AC; Pena L; Angel M; Solórzano A; Albrecht R; Perez DR; García-Sastre A; Palese P
    J Virol; 2009 Feb; 83(4):1742-53. PubMed ID: 19073731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.